Our study has identified the METTL14/ITGB4 axis with its metastasis-regulating role and with its related molecular mechanisms in ccRCC, which may function as a potential diagnostic and therapeutic target for this malignancy in the future. Here, METTL14 is linked to nonpapillary renal cell carcinoma.